An Alternative Inactivant for Rift Valley Fever Virus using Cobra Venom-derived L-Amino Oxidase, which is Related to its Immune Potential

AUTOR(ES)

Al-Olayan, Ebtesam M, Mohamed, Aly F, El-Khadraqy, Manal F, Shebl, Rania I, Yehia, HanryM

FONTE

Braz. arch. biol. technol.

DATA DE PUBLICAÇÃO

31/10/2016

RESUMO

ABSTRACT Vaccine improvement depends on the formulation, adjuvant type and inactivant used. The type of formulation may interfere with immunogenicity. The present work aimed to evaluate the inactivation activity and related immune potential of the Cobra venom-derived LAO enzyme compared to the currently used inactivants (BPL and formalin) for both animal and human vaccines. The RVF virus was completely inactivated within 6 hrs, 4 hrs and 2 hrs after treatment with Formalin, LAO and BPL, respectively. The vaccine potency [ED50] was arranged in a descending order from formalin (0.016) to BPL (0.005) and LAO (0.002). The total IgG levels, Neutralizing Index (NI) and Interferon levels were significantly increased compared to those detected after immunization with the BPL- and Formalin-inactivated vaccine candidates.

Documentos Relacionados

• Purification and antibacterial activities of an L-amino acid oxidase from king cobra (Ophiophagus hannah) venom
• Purification of an L-amino acid oxidase from Bungarus caeruleus (Indian krait) venom
• Antimicrobial activity of an L-amino acid oxidase isolated from Bothrops leucurus snake venom
• The l-Amino Acid Oxidase of Molds 1
• Snake venom L-amino acid oxidases: an overview on their antitumor effects